Top Markets
Coin of the day
OnKure Therapeutics, Inc. OnKure Therapeutics, Inc.

OnKure Therapeutics, Inc.

OKUR
Rank in Stocks #19593
OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a... OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a biopharmaceutical company primarily engaged in the creation and advancement of precise therapeutic agents for cancer. A core area of their research centers on developing highly selective inhibitors for histone deacetylases. Their current pipeline features OKI-179, an inhibitor specifically engineered to combat a wide spectrum of malignancies, including both blood-related cancers and solid tumor formations.
Share Price
$3.86
Last synced: 2026-08-25
Market Cap
$156.32M
Change (1 day)
-0.77%
Change (1 year)
40.36%
Country
US
Trade OnKure Therapeutics, Inc. (OKUR)

Category

EPS for OnKure Therapeutics, Inc. (OKUR)
EPS as of 2026 TTM: 0
According to OnKure Therapeutics, Inc. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for OnKure Therapeutics, Inc. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
$17.32 -
US
$27.74 -
NL
$-7.98 -
US
$-5.29 -
AU
- -
CH